Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations
Recombinant growth hormone improves growth and adult height in patients [...]
Recombinant growth hormone improves growth and adult height in patients [...]
ERN BOND Thematic meetings 4th Meeting on Rare Bone Diseases [...]
Workshop “Patient priorities in ERN BOND beyond Quality of Life” [...]
Bone Curriculum Symposium and the PreSymposium on Rare Bone Diseases [...]
Osteogenesis Imperfecta: News in therapy (IT) XVII Congresso OrtoMed, Florence, [...]
CPMS: A new international communication tool for orthopedics (IT) SIOT [...]
The rare disease network in europe and the importance of [...]
Update on ERN-BOND, CHUC’s skeletal dysplasias multidisciplinary team and on [...]
Can HR-pQCT complement DXA in rare skeletal disease? Preliminary results [...]
Healthcare pathway: ERNs biological samples (from individual to ecosystem) (EN) [...]
ERN-BOND is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are Funded by the European Commission. For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern
Funded by the European Union
ERN BOND Specific Grant Agreement no. 101157116
Coordinating Center
Istituto Ortopedico Rizzoli
via G.C.Pupilli, 1 – 40136 Bologna – Italy
The contents of this website represents the views of the network and
is its sole responsibility; and do not necessarily reflect the opinion of the European Union
Co-funded by the European Union
ERN BOND Specific Grant Agreement no. 101157116
Coordinating Center
Istituto Ortopedico Rizzoli
via G.C.Pupilli, 1 – 40136 Bologna – Italy
The contents of this website represents the views of the network and is its sole responsibility; and do not necessarily reflect the opinion of the European Union